Legal & General Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $330M | Sell |
|
|||||
|
2025
Q1 | $326M | Buy |
|
|||||
|
2024
Q4 | $312M | Sell |
|
|||||
|
2024
Q3 | $287M | Buy |
|
|||||
|
2024
Q2 | $397M | Sell |
|
|||||
|
2024
Q1 | $428M | Sell |
|
|||||
|
2023
Q4 | $347M | Buy |
|
|||||
|
2023
Q3 | $314M | Sell |
|
|||||
|
2023
Q2 | $448M | Buy |
|
|||||
|
2023
Q1 | $384M | Buy |
|
|||||
|
2022
Q4 | $338M | Sell |
|
|||||
|
2022
Q3 | $394M | Sell |
|
|||||
|
2022
Q2 | $474M | Buy |
|
|||||
|
2022
Q1 | $571M | Buy |
|
|||||
|
2021
Q4 | $580M | Sell |
|
|||||
|
2021
Q3 | $509M | Buy |
|
|||||
|
2021
Q2 | $451M | Buy |
|
|||||
|
2021
Q1 | $345M | Sell |
|
|||||
|
2020
Q4 | $380M | Sell |
|
|||||
|
2020
Q3 | $347M | Buy |
|
|||||
|
2020
Q2 | $292M | Buy |
|
|||||
|
2020
Q1 | $259M | Buy |
|
|||||
|
2019
Q4 | $309M | Buy |
|
|||||
|
2019
Q3 | $284M | Buy |
|
|||||
|
2019
Q2 | $238M | Sell |
|
|||||
|
2019
Q1 | $248M | Buy |
|
|||||
|
2018
Q4 | $169M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $122M | Buy |
|
|||||
|
2017
Q2 | $130M | Buy |
|
|||||
|
2017
Q1 | $99.6M | Buy |
|
|||||
|
2016
Q4 | $93.4M | Buy |
|
|||||
|
2016
Q3 | $116M | Sell |
|
|||||
|
2016
Q2 | $98.2M | Buy |
|
|||||
|
2016
Q1 | $82.8M | Buy |
|
|||||
|
2015
Q4 | $72.4M | Buy |
|
|||||
|
2015
Q3 | $63M | Buy |
|
|||||
|
2015
Q2 | $61.5M | Sell |
|
|||||
|
2015
Q1 | $61.6M | Sell |
|
|||||
|
2014
Q4 | $57.5M | Sell |
|
|||||
|
2014
Q3 | $47.5M | Sell |
|
|||||
|
2014
Q2 | $40.5M | Sell |
|
|||||
|
2014
Q1 | $35.5M | Sell |
|
|||||
|
2013
Q4 | $32.9M | Buy |
|
|||||
|
2013
Q3 | $34.5M | Sell |
|
|||||
|
2013
Q2 | $33.7M | Buy |
|